Sacroiliac Joint Fusion Surgery - Global Strategic Business Report

The global market for Sacroiliac Joint Fusion Surgery was valued at US$340.1 Million in 2025 and is projected to reach US$1.3 Billion by 2032, growing at a CAGR of 20.8% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Sacroiliac Joint Fusion Surgery Market - Key Trends & Drivers Summarized

What Is Sacroiliac Joint Fusion Surgery and Why Is It Becoming a Preferred Option for Chronic Pelvic Pain?

Sacroiliac (SI) joint fusion surgery is a minimally invasive or open surgical procedure designed to treat chronic dysfunction or instability of the sacroiliac joint - the joint that connects the base of the spine (sacrum) to the pelvis (ilium). This joint plays a critical role in absorbing shock and transferring loads between the upper body and lower limbs. SI joint dysfunction can cause severe lower back, pelvic, and leg pain, often mimicking symptoms of sciatica or discogenic pain. When conservative treatments such as physical therapy, injections, or radiofrequency ablation fail, surgical fusion becomes a viable long-term solution.

The procedure involves the placement of screws, cages, or implants - often using a lateral or posterior approach - to stabilize the joint and encourage bone growth for permanent fusion. Minimally invasive SI joint fusion, which is performed with fluoroscopic or CT guidance, has gained traction due to its reduced operative time, smaller incisions, less blood loss, and faster recovery. The surgery significantly improves pain relief, functional mobility, and quality of life for patients suffering from debilitating SI joint disorders, particularly those with trauma, degeneration, postpartum instability, or prior lumbar fusion.

What Innovations Are Enhancing the Precision and Outcomes of SI Joint Fusion Procedures?

The sacroiliac joint fusion market is rapidly evolving with technological advancements aimed at improving surgical accuracy, minimizing complications, and accelerating recovery. Minimally invasive techniques have become the gold standard, driven by the development of percutaneous fusion systems that require only a small incision and fluoroscopy-assisted implant placement. These systems reduce hospital stays, minimize tissue disruption, and enable same-day discharge in many cases. 3D imaging and intraoperative navigation technologies are being increasingly integrated into surgical workflows, allowing for more precise placement of implants and real-time confirmation of fusion device positioning.

Implant design has seen significant innovation, with manufacturers introducing porous titanium-coated implants, 3D-printed devices, and bone grafting materials that enhance osteointegration and long-term joint stability. Some implants now feature specialized surface textures or coatings that promote bone in-growth and reduce the risk of loosening. Robotic-assisted surgery is also being explored to improve reproducibility and accuracy in complex or anatomically challenging cases.

In addition, post-operative protocols are being optimized through enhanced recovery after surgery (ERAS) pathways, which include multimodal pain management, early ambulation, and patient education to speed up recovery and reduce complication rates. These improvements are encouraging broader surgeon adoption and making SI joint fusion more accessible to patients earlier in their treatment continuum.

Which Patient Groups and Clinical Trends Are Expanding the Scope of SI Joint Fusion?

The demand for SI joint fusion surgery is growing across several demographic and clinical segments. Middle-aged and elderly populations are the primary patient base, especially those with degenerative sacroiliitis, pelvic instability, or a history of spinal fusion. Studies show that a significant portion of post-lumbar fusion patients develop SI joint dysfunction due to altered biomechanics, leading to increased referrals for SI joint evaluation and potential fusion. Women - particularly postpartum patients - are also disproportionately affected due to hormonal changes and increased pelvic stress during childbirth.

Furthermore, trauma-related SI joint injuries, inflammatory joint diseases, and anatomic abnormalities are leading to earlier diagnosis and surgical intervention. Advances in diagnostic imaging and clinical awareness are helping physicians differentiate SI joint pain from lumbar spine disorders, resulting in more accurate and timely treatment pathways. Patients with chronic lower back pain who fail to respond to traditional therapies are increasingly being evaluated for SI joint pathology as a primary or secondary cause.

Healthcare providers and payers are also recognizing the cost-effectiveness of SI joint fusion in select patients, as it reduces long-term pain management costs, improves mobility, and enables a return to work or daily activity. As patient-reported outcome measures (PROMs) and value-based healthcare models become more prominent, sacroiliac joint fusion surgery is emerging as a clinically validated and economically viable treatment option.

What Is Fueling the Growth of the Global Sacroiliac Joint Fusion Surgery Market?

The growth in the global sacroiliac joint fusion surgery market is driven by several factors, including increasing prevalence of chronic lower back and pelvic pain, expanding clinical acceptance of SI joint pathology, and technological advancements in minimally invasive surgical devices. Rising awareness among orthopedic and spine specialists, along with the development of specialized diagnostic algorithms, is resulting in more accurate diagnosis and earlier surgical referrals.

Innovations in implant design, robotic navigation, and outpatient surgical techniques are improving clinical outcomes, reducing hospital costs, and shortening recovery time - further enhancing patient and provider confidence. The growing demand for less invasive orthopedic procedures and the global shift toward ambulatory care models are also contributing to market growth, particularly in North America and Europe.

Moreover, favorable reimbursement policies in developed markets, increased availability of specialized training programs, and strategic investments by medical device manufacturers are accelerating procedure adoption. Emerging markets in Asia-Pacific and Latin America are beginning to show growth potential as healthcare infrastructure improves and spinal care awareness spreads. With a strong convergence of clinical demand, surgical innovation, and patient-centered care models, the sacroiliac joint fusion surgery market is poised for sustained expansion globally.

Report Scope

The report analyzes the Sacroiliac Joint Fusion Surgery market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:

• Segments: Indication (Degenerative Sacroiliitis, Sacral Disruption); Type (MIS, Open); Approach (Dorsal & Anterior, Lateral); Product (Implants, Accessories); End-Use (Hospitals, Ambulatory Surgery Centers, Others).
• Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Degenerative Sacroiliitis segment, which is expected to reach US$952.1 Million by 2032 with a CAGR of a 22.4%. The Sacral Disruption segment is also set to grow at 17.2% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, valued at $92.7 Million in 2025, and China, forecasted to grow at an impressive 27% CAGR to reach $304.2 Million by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Sacroiliac Joint Fusion Surgery Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Sacroiliac Joint Fusion Surgery Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Sacroiliac Joint Fusion Surgery Market expected to evolve by 2032?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2032?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as Alphatec Spine, Inc., Camber Spine Technologies, LLC, CoreLink Surgical, CornerLoc, DePuy Synthes (Johnson & Johnson) and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Sacroiliac Joint Fusion Surgery market report include:

• Alphatec Spine, Inc.
• Camber Spine Technologies, LLC
• CoreLink Surgical
• CornerLoc
• DePuy Synthes (Johnson & Johnson)
• Globus Medical, Inc.
• Integra LifeSciences Holdings Corp.
• Life Spine, Inc.
• Medtronic plc
• Nevro Corp.
• NuVasive, Inc.
• Orthofix Medical Inc.
• PainTEQ
• SI-BONE, Inc.
• SIGNUS Medizintechnik GmbH
• Tenon Medical, Inc.
• VYRSA Technologies
• Xtant Medical Holdings, Inc.
• Zimmer Biomet Holdings, Inc.
• Zyga Technology, Inc.

What Sets This Report Apart From Others?

• Grounded in Domain Expert Perspectives: Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.
• Captures Early Market Signals: Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.
• Draws From a Broad, Validated Intelligence Base: Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.
• Connects Signals With Strategic Market Direction: Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.
• Provides In-Depth Company Intelligence: Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.
• Market Share Is Examined Where It Matters: A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, our reports extend market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.